Other News

CinCor Pharma Announces Presentation of Phase 1 Clinical Data for Baxdrostat at the Upcoming European Society of Cardiology 2022 Congress

WALTHAM, Mass., Aug. 22, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (NASDAQ: CINC) today announced that the company will present Phase 1 clinical data on lead candidate baxdrostat as part of a poster presentation at the upcoming European Society of Cardiology (ESC) Congress taking place August 26-29, 2022, virtually and […]

Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

MORRISVILLE, N.C., Aug. 22, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) today announced the grant of inducement stock options exercisable for an aggregate of 7,000 shares of Liquidia’s common stock to newly hired non-executive employees under the Liquidia Corporation 2022 Inducement Plan (the “Inducement Plan”). Each stock option was […]

Miracor Medical Announces FDA IDE Approval For PiCSO® Pivotal Study

AWANS, Belgium–(BUSINESS WIRE)–Miracor Medical SA (Miracor Medical) has announced the approval of an Investigational Device Exemption (IDE) from the FDA, enabling the company to initiate a pivotal study with its Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) technology. The PiCSO-AMI-II multicenter, randomized trial will enroll 300 patients with anterior ST-segment Elevation […]

LimFlow Appoints Jenny Gaffney as Vice President, Health Economics and Reimbursement

PARIS–(BUSINESS WIRE)–LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), today announced the appointment of Jenny Gaffney as Vice President, Health Economics and Reimbursement. Ms. Gaffney brings to LimFlow over 15 years of rich […]

IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study

Dr. Christopher Kellner from Mount Sinai Health System successfully enrolled the first patients in the DIVE (Deployment of Irrigating Intraventricular Catheter System) study. DIVE is designed to measure the effectiveness of IRRAflow to treat intraventricular hemorrhage versus standard EVD treatment. The Neurosurgery and Neurology Departments at The Mount Sinai Hospital were recently ranked […]

Medtronic reports first quarter fiscal 2023 financial results

Revenue exceeds guidance, with known supply chain challenges impacting results; notable strength in Pacing, Cardiac Surgery, Core Spine in the U.S., and Diabetes in Europe DUBLIN, Aug. 23, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2023, which ended July 29, 2022. Key Highlights GAAP […]

Merck Receives Fast Track Designation from the U.S. FDA for MK-2060, an Investigational Anticoagulant Therapy

Phase 2 Study of MK-2060 Currently Ongoing in People with End-Stage Renal Disease Receiving Hemodialysis RAHWAY, N.J.–(BUSINESS WIRE)– Merck, (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Merck’s investigational anticoagulant therapy […]

Medtronic announces cash dividend for second quarter of fiscal year 2023

DUBLIN, Aug. 18, 2022 /PRNewswire/ — The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 18, 2022, approved the fiscal year 2023 second quarter cash dividend of $0.68 per ordinary share, representing an 8% increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in May […]

Caregility and Eko Partner to Bring Smart Stethoscope Technology to Award-Winning Enterprise Telehealth Platform

The Caregility Cloud™ and Eko Connect integration addresses virtual care gaps by providing a more comprehensive physical exam experience to care teams and patients EATONTOWN, N.J. and OAKLAND, Calif., Aug. 18, 2022 /PRNewswire/ — Caregility, an enterprise telehealth platform company, and Eko, the market leader in stethoscopes for telehealth, today announced an integration partnership. Caregility’s cloud platform […]

PaceMate™ Co-Founders to Speak at HRX 2022, the Heart Rhythm Society’s Cardiovascular Digital Health Summit

First Annual HRX Meeting to Assemble Cardiovascular Innovators Focused on Transforming Patient Care TAMPA, Fla., Aug. 17, 2022 /PRNewswire/ — PaceMate, one of the nation’s fastest-growing cardiac rhythm management and remote patient monitoring companies, announced two of its co-founders have been chosen to speak at HRX 2022, the Heart Rhythm Society’s cardiovascular […]